Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 26, 16:00
2705.00
16.5 (0.61%)
VOLUME 14,126
LIVE
NSE
Jul 26, 15:52
2707.35
15.2 (0.56%)
VOLUME 174,665
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
USFDA observations beneficial in long run: Dr Reddy's

7.45 am | 24 Jul 2017 |  Source: PTI

"The remedial actions triggered by the USFDA observations are unmistakably beneficial to us in the long run and it has helped us accelerate the pace o...

Hold Dr Reddys; target of Rs 2660: Edelweiss

6.37 pm | 12 Jul 2017 |  Source: Moneycontrol.com

Edelweiss' is bullish on Dr Reddys has recommended Hold rating on the stock with a target price of Rs 2660 in its research report dated July 10, 2...

Buy Dr Reddy’s Labs; sell Pidilite Industries: Mitessh Thakkar 

11.59 am | 07 Jul 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com is of the view that one may buy Dr Reddy’s Labs and sell Pidilite Industries....

Dr Reddy’s says pricing pressure in US to be less severe in FY18

7.05 pm | 06 Jul 2017 |  Source: Moneycontrol.com

Introducing complex generics in the US and upgraded portfolio mix to help, drugmaker says....

Expect lower Q1 sales in India due to GST implementation: DRL

9.31 pm | 03 Jul 2017 |  Source: PTI

Drug major Dr Reddy's Laboratories expects the first quarter of the ongoing fiscal to witness a temporary decline in sales in India due to de-stoc...

Buy Dr Reddy's Labs, Britannia Industries: Mitessh Thakkar 

3.33 pm | 30 Jun 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests buying Dr Reddy's Labs and Britannia Industries....

Preparing for GST implementation for past few months: DRL's Chakraborty 

11.30 am | 30 Jun 2017 |  Source: CNBC-TV18

In the latest, CNBC-TV18's Ekta Batra and Vikas Dandekar caught up with Saumen Chakraborty, CFO of Dr Reddy's Laboratories (DRL) and asked him...

Prefer Dr Reddy's, Sun Pharmaceutical: Hemant Thukral 

12.09 pm | 28 Jun 2017 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money is of the view that one may prefer Dr Roddy’s Laboratories and Sun Pharmaceutical....

Replacing Obamacare by new law in US risk to business: Dr Reddy's

2.10 pm | 25 Jun 2017 |  Source: PTI

In March 2017, the US House of Representatives passed the 'American Health Care Act' to replace the PPACA (Obamacare)....

Stocks in the news: Dr Reddy's, Glenmark, Reliance Defence, Ramky Infra, Petronet LNG 

8.15 am | 22 Jun 2017 |  Source: CNBC-TV18

Dr Reddy's Labs | Sun Pharma | Lupin | Glenmark Pharma | Coal India | Reliance Defence | Ramky Infra | Idea Cellular | Petronet LNG | Prism Cement...

Dr.Reddy's says scouting for in-licensing opportunities to expand specialty portfolio

9.44 pm | 20 Jun 2017 |  Source: Moneycontrol.com

“While we develop novel agents ourselves, we continue to seek licensing and development opportunities with third parties to further expand our produ...

Dr Reddy's may file two new drugs with FDA by 2019

2.35 pm | 20 Jun 2017 |  Source: PTI

According to filing with the US Securities and Exchange Commission, the city-based pharma company is expected to file the New Drug Application (NDA) w...

Indian pharma companies should increase base of sales in next few years: Nirmal Bang 

9.58 am | 19 Jun 2017 |  Source: CNBC-TV18

Formulations plant of Dr Reddy's Laboratories at Srikakulam gets inspected and gets 1 observation from United States Foods and Drug Authority (US-...

Dr.Reddy's gets one USFDA observation for its Srikakulam formulation plant

9.52 pm | 16 Jun 2017 |  Source: Moneycontrol.com

“We have been issued a Form 483 with one observation, which we are addressing,” the company said....

Remain invested in Dr Reddy's Laboratories: Prakash Gaba 

3.30 pm | 16 Jun 2017 |  Source: CNBC-TV18

According to Prakash Gaba of prakashgaba.com, one may remain invested in Dr Reddy's Laboratories....

Hold Dr Reddy's Laboratories; target of Rs 2450: Axis Direct

3.51 pm | 22 May 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Dr Reddy's Laboratories with a target price of Rs 2450 in its research report dated May 18, 2017....

Hold Dr Reddy’s Laboratories; target of Rs 2610: ICICI Direct

4.58 pm | 16 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Dr Reddy’s Laboratories with a target price of Rs 2610 in its research report dated May 15, 2017....

Hold Dr. Reddys Laboratories; target of Rs 2660: Edelweiss

4.50 pm | 15 May 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Dr. Reddys Laboratories with a target price of Rs 2660 in its research report dated May 12, 2017....

Dr Reddy's Labs Q4: Analysts see hope in US biz recovery, reduced regulatory concerns

3.54 pm | 15 May 2017 |  Source: Moneycontrol.com

Brokerages largely remain optimistic about the pharma major’s improvement in US business as well as reduced regulatory risks, while some also highli...

Dr Reddy's Labs Q4 profit soars 175% on strong EM biz, misses earnings estimates

3.59 pm | 12 May 2017 |  Source: Moneycontrol.com

"FY17 has been a challenging year due to lack of new product approvals for the US market," said GV Prasad, chief executive officer and co-chairman of ...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.